Bacteria, viruses, fungi and parasite are potential causes of emerging, reemerging and unidentified infectious diseases (ERUs). A great number of pathogens have caused epidemics and even outbreaks which include SARS, MERS, Ebola, TB, H1N1, Malaria, Cholera, and now Monkeypox, unidentified hepatitis and COVID-19. These ERUs have caused more than one billion cases and over several million deaths worldwide, creating a serious public health threat, particularly in developing countries. Because of globalization, frequent migration, and climate change, the emergence and spread of those diseases have increased in recent years. Consequently, early and accurate diagnosis is of great importance for the effective surveillance-response as it could provide evidence-based proof for the following decision-making and interventions. In addition, investigating the genomic evolution is a useful method to measure and track the source of infection. This could help to dissect the transmission route of pathogens and predict and assess the potential risks of the outbreaks caused by them.
This Research Topic would like to invite our colleagues to provide novel insights into the diagnosis and the analysis of genomic evolution of ERUs. In particular, we would like submissions of the following areas: diagnostic technology (RT-PCR, RPA, CRISPR, Microarray flow), sequence skill and platform (Illumina, Nanopore, PacBio), new biomarker and mechanism for drug resistance identification (MRSA, VRSA, MDR-TB, ESBLs), and phylogenetic analysis (MAFFT, Mega, FastTree) of pathogens. Manuscripts covering epidemiological study (models, risk prediction), molecular epidemiology for disease transmission are also welcome.
We welcome submissions of Original Research, Review, Mini-Review, Meta-analysis, Systemic Reviews, and Case Reports encompassing epidemiological, translational, and basic research focusing on, but not limited to, the following aspects:
• Novel diagnostic technology
• New sequence skill, platform, and phylogenetic analysis
• New findings on drug resistance biomarkers and mechanism
• New therapeutic targets for the development of vaccines and drugs
• Risk evaluation of disease transmission applying mathematical model
• Molecular epidemiological-related study
Bacteria, viruses, fungi and parasite are potential causes of emerging, reemerging and unidentified infectious diseases (ERUs). A great number of pathogens have caused epidemics and even outbreaks which include SARS, MERS, Ebola, TB, H1N1, Malaria, Cholera, and now Monkeypox, unidentified hepatitis and COVID-19. These ERUs have caused more than one billion cases and over several million deaths worldwide, creating a serious public health threat, particularly in developing countries. Because of globalization, frequent migration, and climate change, the emergence and spread of those diseases have increased in recent years. Consequently, early and accurate diagnosis is of great importance for the effective surveillance-response as it could provide evidence-based proof for the following decision-making and interventions. In addition, investigating the genomic evolution is a useful method to measure and track the source of infection. This could help to dissect the transmission route of pathogens and predict and assess the potential risks of the outbreaks caused by them.
This Research Topic would like to invite our colleagues to provide novel insights into the diagnosis and the analysis of genomic evolution of ERUs. In particular, we would like submissions of the following areas: diagnostic technology (RT-PCR, RPA, CRISPR, Microarray flow), sequence skill and platform (Illumina, Nanopore, PacBio), new biomarker and mechanism for drug resistance identification (MRSA, VRSA, MDR-TB, ESBLs), and phylogenetic analysis (MAFFT, Mega, FastTree) of pathogens. Manuscripts covering epidemiological study (models, risk prediction), molecular epidemiology for disease transmission are also welcome.
We welcome submissions of Original Research, Review, Mini-Review, Meta-analysis, Systemic Reviews, and Case Reports encompassing epidemiological, translational, and basic research focusing on, but not limited to, the following aspects:
• Novel diagnostic technology
• New sequence skill, platform, and phylogenetic analysis
• New findings on drug resistance biomarkers and mechanism
• New therapeutic targets for the development of vaccines and drugs
• Risk evaluation of disease transmission applying mathematical model
• Molecular epidemiological-related study